Company: SUPN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001356576-25-000017
Chunk: 106

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1C
Chunk 106
---
. The confidential portions of this exhibit have been omitted and are marked accordingly. The confidential portions have been filed separately with the Securities and Exchange Commission pursuant to the Confidential Treatment Request.

††     Certain portions of this exhibit that constitute confidential information have been omitted in accordance with Regulation S-K, Item 601(b)(10)(iv) because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.

#     Exhibits and schedules have been omitted pursuant to Regulation S-K Item 601(a)(5) and will be furnished on a supplemental basis to the Securities and Exchange Commission upon request.

+    Indicates a management contract or compensatory plan, contract or arrangement in which directors or officers participate.

*    Previously filed.

**    Filed herewith.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.SUPERNUS PHARMACEUTICALS, INC.By:/s/ JACK A. KHATTARName:Jack A. KhattarTitle:President and Chief Executive Officer

Date: February 25, 2025 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and the dates indicated below:SignatureTitleDate/s/ JACK A. KHATTARPresident and Chief Executive Officer and Director (Principal Executive Officer)February 25, 2025/s/ TIMOTHY C. DECSenior Vice-President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)February 25, 2025/s/ CHARLES W. NEWHALL, III.Director and Chairman of the BoardFebruary 25, 2025/s/ CARROLEE BARLOW, M.D., PH.D.DirectorFebruary 25, 2025/s/ GEORGES GEMAYEL, PH.D.DirectorFebruary 25, 2025/s/ FREDERICK M. HUDSONDirectorFebruary 25, 2025/s/ BETHANY SENSENIGDirectorFebruary 25, 2025